CS logo
small CS logo
Lafayette Family Cancer Center-EMMC

Brewer, Maine, United States
Medical center in Brewer, Maine
33 Whiting Hill Rd, Brewer, ME 04412

About Lafayette Family Cancer Center-EMMC


""Northern Light Health is dedicated to delivering compassionate, comprehensive cancer care with an experienced staff who work together to develop a cancer treatment plan personalized for each patient. ""
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Lafayette Family Cancer Center-EMMC


During the past decade, Lafayette Family Cancer Center-EMMC conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 33 clinical trials were completed, i.e. on average, 33% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 30 clinical trials were completed. i.e. 76.9% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Lafayette Family Cancer Center-EMMC" #1 sponsor was "National Cancer Institute (NCI)" with 62 trials, followed by "SWOG Cancer Research Network" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "NRG Oncology" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Lafayette Family Cancer Center-EMMC" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Biologics, Inc." with 2 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

Clinical Trials Conditions at Lafayette Family Cancer Center-EMMC


According to Clinical.Site data, the most researched conditions in "Lafayette Family Cancer Center-EMMC" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Stage IV Breast Cancer AJCC v6 and v7" (6 trials) and "Stage IV Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Lafayette Family Cancer Center-EMMC" in a lesser frequency.

Clinical Trials Intervention Types at Lafayette Family Cancer Center-EMMC


Most popular intervention types in "Lafayette Family Cancer Center-EMMC" are "Drug" (95 trials), "Other" (78 trials), "Biological" (53 trials), "Procedure" (36 trials) and "Radiation" (17 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (37 trials), "Laboratory Biomarker Analysis" (33 trials), "Computed Tomography" (20 trials), "Questionnaire Administration" (20 trials) and "Biospecimen Collection" (18 trials). Other intervention names were less common.

Clinical Trials Genders at Lafayette Family Cancer Center-EMMC


The vast majority of trials in "Lafayette Family Cancer Center-EMMC" are 99 trials for "All" genders, 16 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Lafayette Family Cancer Center-EMMC


Currently, there are NaN active trials in "Lafayette Family Cancer Center-EMMC". undefined are not yet recruiting, 33 are recruiting, 64 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Lafayette Family Cancer Center-EMMC, 5 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Lafayette Family Cancer Center-EMMC, 4 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".